Want to see SG:OTX full AI Analyst Report?
Top Page
Medinex Ltd.
(SGX:OTX)
Select Model
Select Model
Rating:69Neutral
Price Target:
S$0.22
â–¼(-9.58% Downside)
Action:Downgraded
Date:10/01/26
Overall score reflects strong financial stability (notably low leverage) and attractive valuation (low P/E and high dividend yield), offset by weak technicals (below major moving averages with negative MACD) and some recent financial softening (2026 revenue decline, lower net margin, and lower free cash flow).
Positive Factors
Conservative balance sheet
Very low leverage gives Medinex substantial financial flexibility over the next several quarters. A strong equity base and declining debt reduce balance-sheet risk, preserve capacity to fund operations, and improve resilience if profitability or cash generation remains uneven.
Negative Factors
Revenue contraction
The latest revenue decline indicates that demand or business activity has not followed a consistently expanding trajectory. If this pattern persists, weaker scale benefits could limit operating leverage, constrain reinvestment capacity, and make future earnings growth more dependent on cost control.
Read all positive and negative factors
Positive Factors
Negative Factors
Conservative balance sheet
Very low leverage gives Medinex substantial financial flexibility over the next several quarters. A strong equity base and declining debt reduce balance-sheet risk, preserve capacity to fund operations, and improve resilience if profitability or cash generation remains uneven.
Read all positive factors
Medinex Ltd. (OTX) vs. iShares MSCI Singapore ETF (EWS)
Market Cap
S$25.56M
Dividend Yield12.73%
Average Volume (3M)16.00K
Price to Earnings (P/E)7.9
Beta (1Y)0.25
Revenue Growth-3.11%
EPS Growth-21.50%
CountrySG
Employees65
SectorHealthcare
Sector Strength45
IndustryMedical - Care Facilities
Share Statistics
EPS (TTM)0.03
Shares Outstanding134,543,840
10 Day Avg. Volume46,020
30 Day Avg. Volume15,996
Financial Highlights & Ratios
PEG Ratio-0.61
Price to Book (P/B)1.82
Price to Sales (P/S)2.42
P/FCF Ratio11.76
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Medinex Ltd. Business Overview & Revenue Model
Company Description
Medinex Limited, an investment holding company founded in Singapore in 2009, specializes in providing extensive professional support services, primarily catering to medical clinics across the country. The company's operations are divided into four...
Medinex Ltd. Financial Statement Overview
Summary
Income Statement
72
Positive
Balance Sheet
86
Very Positive
Cash Flow
68
Positive
| Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 12.41M | 12.81M | 12.58M | 12.97M | 11.99M |
| Gross Profit | 9.96M | 9.93M | 9.68M | 9.48M | 8.57M |
| EBITDA | 2.99M | 3.58M | 1.79M | 2.88M | 4.00M |
| Net Income | 2.22M | 2.83M | 1.03M | 1.70M | 2.81M |
Balance Sheet | |||||
| Total Assets | 19.47M | 20.69M | 20.50M | 22.59M | 22.98M |
| Cash, Cash Equivalents and Short-Term Investments | 5.52M | 5.56M | 5.17M | 4.15M | 6.34M |
| Total Debt | 996.00K | 1.67M | 2.08M | 2.34M | 3.10M |
| Total Liabilities | 2.95M | 3.96M | 4.34M | 4.81M | 5.51M |
| Stockholders Equity | 16.52M | 16.72M | 16.12M | 17.57M | 17.25M |
Cash Flow | |||||
| Free Cash Flow | 2.55M | 3.33M | 2.67M | 2.83M | 2.63M |
| Operating Cash Flow | 2.71M | 3.35M | 2.70M | 3.03M | 2.86M |
| Investing Cash Flow | 670.00K | 243.45K | 1.66M | -2.19M | -16.91K |
| Financing Cash Flow | -3.41M | -3.20M | -3.33M | -3.02M | -3.16M |
Medinex Ltd. Technical Analysis
Neutral
0.24
Price Trends
0.22
Negative
0.22
Negative
0.22
Negative
Market Momentum
>-0.01
Positive
38.25
Neutral
11.11
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SG:OTX, the sentiment is Neutral. The current price of 0.24 is above the 20-day moving average (MA) of 0.21, above the 50-day MA of 0.22, and above the 200-day MA of 0.22, indicating a bearish trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 38.25 is Neutral, neither overbought nor oversold. The STOCH value of 11.11 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for SG:OTX.
Medinex Ltd. Peers Comparison
UnderperformOutperform
Sector (51)
SG:OTX
Medinex Ltd.
0.20
-0.02
-9.17%
SG:1J5
Hyphens Pharma International Ltd.
0.37
0.01
3.11%
SG:40T
ISEC Healthcare Ltd
0.31
-0.03
-9.62%
SG:505
Asiamedic Limited
0.02
>-0.01
-19.05%
SG:546
Medtecs International Corporation Ltd.
0.12
-0.01
-8.73%
SG:MIJ
Alliance Healthcare Group Ltd.
0.19
0.06
50.41%
Medinex Ltd. Corporate Events
Medinex Shareholders Back Dividend, Board Line-Up and Share Issue Mandate at 2026 AGM
Aug 18, 2026
Medinex Ltd. reported the outcomes of its 24 July 2026 annual general meeting in Singapore, where shareholders unanimously approved a final tax-exempt dividend of S$0.0084 per share for the financial year ended 31 March 2026 and endorsed directors...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.